David Ross Kaufman - 17 Jun 2024 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Reporting relationship: Director
Issuer ticker: HOOK
Reported as of: 17 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Jun 2024, 16:15:32 UTC
Prior SEC filing: 09 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Reinhard Kandera, Attorney-in-Fact

Key filing fact

David Ross Kaufman filed Form 4 for HOOKIPA Pharma Inc. (HOOK) on 18 Jun 2024.

Key facts

This page summarizes David Ross Kaufman's Form 4 filing for HOOKIPA Pharma Inc. (HOOK).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 Jun 2024, 16:15.

Change

Previous filing in this sequence was filed on 09 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HOOK transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +49,000
Change %
Price: $0.000000
Shares after: 49,000
Date: 17 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 49,000
Exercise price: $0.7100
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option award shall vest and become fully exercisable on the earlier to occur of (a) June 17, 2025 and (b) the date of the Issuer's next annual meeting of its stockholders.